NHI drug prices for 404 products slashed by 0.83% on average.

Published: 2006-08-21 06:57:00

Updated: 2006-08-21 06:57:00

Taking effect from Sept. 1, the NHI drug prices for 404 products would be reduced by 0.83% on average after reviewing their actual transaction prices for two months from Feb. 20 to April 13 by the HIRA.

The MOHW announced on Aug. 16 that the actual transaction drug prices prevailed in hospit...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK